Sol-Gel Technologies (SLGL) Gains from Investment Securities (2016 - 2018)
Sol-Gel Technologies (SLGL) reported Gains from Investment Securities of $198575.0 for Q4 2018, down 76.63% year-over-year from $849780.0 in Q4 2017, and up 886.07% quarter-over-quarter from $20138.0 in Q1 2018.
Sol-Gel Technologies (SLGL) Gains from Investment Securities (2016 - 2018) Analysis & Trends
Sol-Gel Technologies (SLGL) has 3 years of Gains from Investment Securities data on file, last reported at $198575.0 in Q4 2018.
- Gains from Investment Securities for Q4 2018 came in at $198575.0, down 76.63% year-over-year; the trailing twelve-month figure through Dec 2018 was $198575.0 (down 76.63% YoY), and the FY2025 annual result was $54000.0, up 1250.0% from the prior year.
- Gains from Investment Securities grew to $198575.0 in Q4 2018 per SLGL's latest filing, from $20138.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $849780.0 in Q4 2017 and troughed at $20138.0 in Q1 2018.
- A 3-year average of $367862.0 and a median of $300765.0 in 2016 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2017 and 2018: Gains from Investment Securities jumped 110.89% in 2017, then tumbled 76.63% in 2018.
- A 3-year view of Gains from Investment Securities shows it stood at $402955.0 in 2016, then surged by 110.89% to $849780.0 in 2017, then plunged by 76.63% to $198575.0 in 2018.
- Business Quant data shows SLGL's Gains from Investment Securities at $198575.0 in Q4 2018, $20138.0 in Q1 2018, and $849780.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 198,575.00 |
| Dec 31, 2018 | 198,575.00 |
| Mar 31, 2018 | 20,138.00 |
| Mar 31, 2018 | 20,138.00 |
| Dec 31, 2017 | 849,780.00 |
| Dec 31, 2017 | 849,780.00 |
| Dec 31, 2016 | 402,955.00 |
| Dec 31, 2016 | 402,955.00 |